Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2022
Event: Entry into a Material Definitive Agreement.
Key Financial Metrics
This filing reports a specific transaction rather than periodic financial performance. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
- Transaction Value: $797,720 (Total purchase price for equipment and contracts).
- Counterparty: ABF SANUWAVE, LLC.
Material Changes
On February 17, 2022, the Company entered into a Master Equipment and Contracts Purchase Agreement with ABF SANUWAVE, LLC. Key terms include:
- Asset Transfer: The Company sold certain equipment and associated contracts to ABF.
- Continued Involvement: ABF engaged the Company to administer the purchased contracts and service the purchased equipment.
- Profit Sharing: The Company retains the right to profit sharing on transferred assets once amounts received by ABF exceed an agreed-upon target price for the asset.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the customary representations, warranties, and covenants included in the agreement. The agreement is qualified in its entirety by reference to the full text filed as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (Master Equipment and Contracts Purchase Agreement) for specific details on the "agreed upon target price" triggering profit sharing.
- Verify the accounting treatment of the $797,720 transaction in the Company's next periodic financial report (e.g., 10-Q or 10-K) to determine if it is recorded as a gain, asset sale, or other income.
- Assess the impact of retaining service and administration obligations on future operating expenses and revenue recognition.
- Confirm the relationship between SANUWAVE Health, Inc. and ABF SANUWAVE, LLC to evaluate potential related-party transaction implications.